FAP and type 2 diabetes mellitus: Skeletal muscle biopsies from subjects with type 2 diabetes (T2D) have been recently described to retain a higher level of FAP content with significant changes in FAP population, due to an increase in the pathogenic phenotype FAPCD90+, which is the cellular driver to muscle niche degeneration found in diabetes [39].